Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility

• Status: Withdrawn
• Trial end date: 2018-05-30
• Target enrollment: 0
• Participant gender: Male

Summary

To study the effect of coenzyme Q10 on semen parameters in men with idiopathic infertility

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: PharmEvo Pvt Ltd
• Treatments: Coenzyme Q10; Ubiquinone

Criteria

Inclusion Criteria:

• To sign the Informed Consent form

• Patients will be recruited in the study if they will fulfilled the criteria of history of primary infertility of more than 2 years, abnormal sperm count and motility

• age between 20 and 50 years

• No known medical or surgical condition which can result in infertility

Exclusion Criteria:

• Voluntary withdrawal

• Poor compliance of visit/treatment

• A history of cancer chemotherapy or radiotherapy

• A history of genital disease such as cryptorchidism and varicocele; a history of genital surgery

• Body mass index 30 kg/m or greater; any endocrinopathy

• Ychromosome microdeletions or karyotype abnormalities

• leukocytospermia

• Drug or substance abuse; tobacco use;

• Use of anticonvulsants, androgens or antiandrogens

• Significant liver (serum bilirubin greater than 2.0 mg/dl)

• Renal function (serum creatinine greater than 2.0 mg/dl) impairment

• Patients with severe oligozoospermia (less than 5 X 106/ml), azoospermia and testicular volume less than 12 ml will also excluded from study.